It is known that antagonism of AT1 receptor can lower ROS generation and expression of several NADPH oxidase subunits in SHR (Zalba et al., 2000; Akasaki et al., 2006), however this is the first report that Ang II increases PDI expression during the development of hypertension. The gene discussed is FMO5; the disease is hypertensive disorder.